Jeffrey D Janus

This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: International Stem Cell Corporation, Other. Active years: 2010-2022.

USPTO Granted Patents = 9 (Patent Applications = 6)

% Patents Active = 44.4

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

San Ramon, CA (US) (2018)
San Diego, CA (US) (2012 - 2019)
Frederick, MD (US) (2010 - 2022)

Company Filing History:

8 out of 15

International Stem Cell Corporation

patents

1 out of 834,453

Other

patents

Years Active: 2010-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11324778 - Parthenogenic activation of human oocytes for the production of neuronal cells (2022-05-10),

2. 10172890 - Topical skin care compositions and methods (2019-01-08),

3. 9920299 - Patient-specific stem cell lines derived from human parthenogenetic blastocysts (2018-03-20),

4. 8986995 - Methods of deriving differentiated cells from stem cells (2015-03-24),

5. 8945083 - Cell culture medium container assembly (2015-02-03),

6. 8420393 - Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension (2013-04-16),

7. 8268621 - Methods of deriving definitive endoderm cells from pluripotent parthenogenetic stem cells (2012-09-18),

8. 7935100 - Cell culture medium container assembly (2011-05-03),

9. 7732202 - Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells (2010-06-08),

Title: The Innovative Contributions of Jeffrey D. Janus

Introduction

Jeffrey D. Janus is a prominent inventor based in Frederick, MD, known for his significant contributions to the field of stem cell research. With a total of nine patents to his name, Janus has made remarkable strides in the development of methods for producing human stem cells and topical skin care compositions.

Latest Patents

Among his latest patents, Janus has developed methods for parthenogenic activation of human oocytes for the production of neuronal cells. This innovative approach involves manipulating tension levels and using serine threonine kinase inhibitors to activate human oocytes. The process includes isolating inner cell masses from the activated oocytes and culturing these cells under specific conditions. Additionally, Janus has disclosed methods for producing stem cells from activated oocytes without the use of non-human animal products, utilizing human feeder cells for culturing. Another notable patent focuses on topical skin care compositions that incorporate lysate of human parthenogenetic stem cells. These compositions are designed to reduce visible signs of skin aging and cellulite, showcasing Janus's versatility in applying his research to practical applications.

Career Highlights

Throughout his career, Janus has worked with various organizations, including the International Stem Cell Corporation. His work has been pivotal in advancing the understanding and application of stem cell technology, contributing to both scientific knowledge and commercial products.

Collaborations

Janus has collaborated with notable colleagues in the field, including Elena S. Revazova and Leonid N. Kuzmichev. These partnerships have further enriched his research and development efforts, leading to innovative solutions in stem cell applications.

Conclusion

Jeffrey D. Janus stands out as a key figure in the realm of stem cell research and innovation. His patents and collaborative efforts reflect a commitment to advancing science and improving human health through innovative technologies.